A fatty liver condition emerges when the liver gathers an excessive amount of fat, potentially leading to liver failure if not addressed. Yet, adopting healthy dietary habits can prevent or manage this condition.
1. Patients randomized to have Zinc (Zn) supplementation incorporated into an 8-week diet and exercise intervention for patients with NAFLD led to decreases in waist circumference, body-mass index (BMI), aspartate transaminase (AST), total cholesterol, and low-density lipoprotein (LDL-C) levels compared to controls. Evidence Rating Level: 1 (Excellent) Non-alcoholic fatty liver disease (NAFLD) is rising in
The ultrasound prevalence of NAFLD was 23% among a cohort of patients with IBD, with study results further identifying several clinical characteristics associated with IBD-NAFLD including age, gender, BMI, and waist circumference.
Results from the 24-week extension period of the phase 2b ENLIVEN trial showed sustained improvements in liver fat, fibrosis, and inflammation among those treated with 30 mg weekly and 44 mg biweekly pegozafermin.
Findings were presented at The Liver Meeting 2023 from the American Association for the Study of Liver Diseases and showed empagliflozin reduced liver fat content in both patients with T2DM and nondiabetic patients.